From mcsxv3 from mizzou.edu  Tue Mar 10 15:18:39 2009
From: mcsxv3 from mizzou.edu (mcsxv3)
Date: Tue Mar 10 16:05:32 2009
Subject: [Cell-biology] help
Message-ID: <49B6CB1F.4080405@mizzou.edu>

Is anybody aware if there are any immortalized neutrophil or monocyte 
cell lines useful to study cell adhesion during tethering and rolling to 
the endothelium?

Any help will be highly appreciated.

Mari Staiculescu.

From scimedweb from mail.com  Fri Mar 20 05:54:26 2009
From: scimedweb from mail.com (scimedweb@mail.com)
Date: Fri Mar 20 11:34:42 2009
Subject: [Cell-biology] An update on tumor suppressor genes in breast cancer
	(book).
Message-ID: <664b7d45-33bd-4d04-a23f-12d75f8180ce@w34g2000yqm.googlegroups.com>

Tumor suppressor genes in breast cancer (book).

by Marc Lacroix
InTextoResearch, Baelen (Wallonia), Belgium
Nova Sciences Publishers, New York, ISBN 978-1-60456-326-9

https://www.novapublishers.com/catalog/product_info.php?products_id=3D6866

Breast cancer is characterized by the accumulation of genetic
alterations, including point mutations and loss of entire DNA regions
(=93loss of heterozygosity=94 or LOH). Among genes that are affected by
such events, the =93tumor suppressor genes=94 (TSGs) have a peculiar
interest since they often occupy pivotal positions in regulatory
networks that control the cell cycle and/or encompass various signal
transduction cascades. While a number of genes have been suggested as
candidate TSGs in breast cancer, only a few of them have been
confirmed in this status. They include TP53, BRCA1, BRCA2=85and are
mainly involved in the control of DNA repair, cell proliferation,
apoptosis and signaling. Some TSGs are linked to familial (hereditary)
forms of breast cancer. The exact definition of what is a TSG is still
debated. Recently, genes not affected by mutation or even LOH, but
occasionally methylated have been considered as TSGs.



Genes discussed:


On chromosome 1: CLCA2, DIRAS3 (ARHI, RHOI, NOEY2), LPHH1, TTC4,
RAD54L (RAD54), FABP3 (MDGI), RUNX3 (CBFA3, AML2), PRDM2 transcript 1
(RIZ transcript 1), SFN (14-3-3s)

On chromosome 3: ROBO1 (DUTT1), PTPG (PTPRG); FHIT (FRA3B, included),
PB1 (BAF180), RASSF1 transcript A, RBM5 (LUCA-15, H37), TUSC4 (NPRL2),
TMEM158 (RIS1), SEMA3B, TGFBR2 (HNPCC6), APRG1 (C3ORF35), RARB
transcript 2, VHL, ATR (FRP1)

On chromosome 4: SLIT2, PRDM5, HPGD (PGDH1)

On chromosome 5: DAB2 (C9), APC, IRF1

On chromosome 6: PLAGL1 (ZAC, LOT1), LATS1 (WARTS), IGF2R (MPRI)

On chromosome 7: ST7 (TSG7, RAY1, FAM4A1, HELG)

On chromosome 8: SFRP1 (FRP), DLC1 (ARHGAP7), BNIP3L, RHOBTB2 (DBC2),
LZTS1 (FEZ1, F37), MTUS1 (ATIP), MCPH1 (BRIT1), ST18

On chromosome 9: CDKN2A (p16INK4A, p14ARF), SYK, DAB2IP (AIP1), TSC1

On chromosome 10: PTEN (MMAC1), PDCD4, MGMT

On chromosome 11: WT1, TSG101, CDKN1C (BWS), CST6, IGSF4 (TSLC1, ST17,
NECL2), ATM, LOH11CR2A (BCSC1)

On chromosome 12: CCND2

On chromosome 13: LATS2, BRCA2 (FANCD1), RB1, ARL11 (ARLTS1)

On chromosome 15: RAD51 (RECA)

On chromosome 16: TSC2, CYLD, CTCF, CDH1, TERF2 (TRF2), TERFIP, FBXL8,
LRRC29, ATBF1, WWOX, FBXO31, CBFA2T3 transcript B (MTG16), CPNE7,
CDK10 (PISSLRE), FANCA, GAS11, C16ORF3

On chromosome 17: MAP2K4 (SERK1, SEK1, PRKMK4, MEK4), GABARAP, TP53,
IC1, OVCA1(DPH1, DPH2L1), BRCA1, BECN1, SLC9A3R1

On chromosome 18: EPB41L3, SMAD4 (ELAC1, DPC4), DCC

On chromosome 19: STK11 (LKB1)

On chromosome 22: SMARCB1 (BAF47, SNF5), RRP22, TMPRSS6, CHEK2 (CHK2,
RAD53), NF2, PRR5